Edoardo
@EdoGal89
Followers
159
Following
2K
Media
125
Statuses
2K
Joined March 2012
Is this for real?! Thanks to all my coauthors, collaborators and friends @BecherLab, and @NatureMedicine of course. Another step closer to the understanding of #MultipleSclerosis, aiming to provide a better care for these patients.
nature.com
Nature Medicine - A machine learning approach using high-dimensional phenotypic and functional profiling data identifies a multiple sclerosis-specific T cell population that is reduced following...
0
3
15
Original Article: Common Diseases in Clinical Cohorts — Not Always What They Seem https://t.co/PBk8feriL4 Editorial: A Rare-in-Common Paradigm for Precision Genomic Medicine https://t.co/wKXF0QInBB
#Genetics
0
11
48
Don’t miss our post #ECTRIMS2025 abstract webinar happening TODAY at 13:00 CEST - featuring one standout abstract from each track — Clinical, Therapy, Pathogenesis, & Imaging & Non-imaging Biomarkers 👉 Secure your spot: https://t.co/KSdPpUqGVE Moderators: Stefan Bittner from
0
1
8
📢 Breaking news: The 2024 revised #McDonaldCriteria have been published in @TheLancetNeuro. Explore the latest evidence shaping #MSDiagnosis. Published by the International Advisory Committee for Clinical Trials in #MS. 👉 https://t.co/8V2lWodMm2
@mssociety #MSResearch #IACCTMS
3
18
54
Brilliant approach with terrific implications in clinical MS. Chapeau
🚨 Paradigm shift in #MultipleSclerosis 🚨 New study in Nature Medicine shows MS is not fixed subtypes but a dynamic continuum of states across 4 dimensions: disability, brain damage, relapses & silent inflammation. 📖 Read: https://t.co/MYvAAI6AiV
#MS #Neurology #AI
0
0
1
Are you a researcher or healthcare professional (HCP) under 40 or in your early career who's attending #ECTRIMS2025 in Barcelona? Join the Young #MS HCP & Researcher Networking Event! 🗓️ 24 Sep 2025, 18:45-20:30 CEST 📍 NeuroNetwork Sign up for free 👉 https://t.co/5DpYXGfiK4
0
4
5
Nature research paper: EBV induces CNS homing of B cells attracting inflammatory T cells https://t.co/iCSDKxjkp7
nature.com
Nature - Epstein–Barr virus infection generates a neuroinvasive B cell subset, which recruits activated T cells to the central nervous system, promoting multiple sclerosis.
3
39
137
🎓 Webcasts from our Summer School in Stockholm this June are now available on #myECTRIMS! Gain insights from leading experts on Visual System Evaluation in #MS and Other Demyelinating Diseases. Watch them here: https://t.co/ZZx9ZubXn0
#ECTRIMSNextGen #MultipleSclerosis
0
2
13
In the latest video in our partnership with @DGlaucomflecken, the BALANCE trial comparing 7 days of antibiotic treatment with 14 days of treatment in patients with bloodstream infection is explained. Access the article for free: https://t.co/A7Z3do3VF6
23
183
779
📢 Last call! Are you an early career #MS professional looking for guidance and support? Join the #ECTRIMS #Mentorship Programme! #ECTRIMSNextGen ✅ Sign up as a mentee and get matched ➡️ https://t.co/VaTyjH4ahh Deadline: 30 June.
0
2
3
Long due but incredibly welcome step forward in MS! A major milestone that will massively impact every aspect of how we understand and treat MS, from trial design to targeting specific biological drivers of disease. Exciting times ahead! #Neuroimmunology #RC2NB #ECTRIMS
The International Advisory Committee on Clinical Trials in #MS met in May to discuss a topic that could reshape the landscape of MS care and research: the revision of MS course descriptors. Learn why this is an important step forward in #MSResearch: ➡️ https://t.co/zsQB5GY1b9
0
1
3
🧬Why do some people develop MS while others do not? No single genetic variant alone can cause MS. Each one adds incrementally to the overall risk – an effect known as polygenicity. Discover more in our latest Spotlight 👉 https://t.co/hcMYK4NXdH
#MS #Genetics
0
2
4
NEW! myECTRIMS now has a #Mentorship Programme for early-career healthcare professional looking for guidance and support. Get matched with an experienced mentor and build valuable connections for your future. ✅ Sign up as a mentee here: https://t.co/VaTyjH4ahh
0
1
3
🚀 Something exciting is on the horizon at ECTRIMS! Over the last year we’ve been working behind the scenes to build a personalised and seamless ECTRIMS experience designed just for you. Stay tuned—myECTRIMS is coming soon!
0
5
18
Congratulations @JensKuhle !
Ending the Year on a High Note! Prof. @JensKuhle (@UniSpitalBasel) has been awarded the Sobek Foundation Award 2024, Europe’s most prestigious honor in MS research! A remarkable recognition for his work on biomarkers transforming MS care. @UniBasel_en #MultipleSclerosis
0
0
0
At ECTRIMS, we are privileged to carry forward Professor Giancarlo Comi’s work, honor his legacy, and pursue his vision. Read ECTRIMS’ tribute to his remarkable career: https://t.co/WSd8fKWvuS
0
6
35
Does checking neurofilament light chain (sNfL) help guide personalized treatment of MS and lead to better outcomes? We'll find out soon. This Swiss Randomized trial will but the biomarker to the test.
pubmed.ncbi.nlm.nih.gov
ClinicalTrials.gov NCT06095271. Registered on October 23, 2023.
0
1
17
Biggest paper yet from the lab out now in @ImmunityCP! It is a massive #openscience resource on #tissueTregs, and what makes #Tregs tick in the #tissues. Spoiler-alert: Tissue Tregs are really different from what we all thought. 🧵 1/21 https://t.co/k8q7LhMewB
19
131
507
Early Bird Registration Still Open for #ECTRIMS2024! Secure your ticket for the leading #MultipleSclerosis congress in Copenhagen from 18-20 September. Save substantially by acting now! Early bird pricing ends on 24 July. Register today ➡️ https://t.co/Q7n7LlV6Zv
0
1
2